- Investing Ideas
- Software Healthcare Sector
Software Healthcare Sector
Results
2166
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2166 companies
Tango Therapeutics
Market Cap: US$4.1b
A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.
TNGX
US$28.56
7D
-8.0%
1Y
321.9%
Concentra Group Holdings Parent
Market Cap: US$4.0b
Provides occupational health services in the United States.
CON
US$31.61
7D
0.7%
1Y
58.4%
ICU Medical
Market Cap: US$3.9b
Develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide.
ICUI
US$157.51
7D
-0.06%
1Y
29.5%
Dyne Therapeutics
Market Cap: US$3.9b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$23.74
7D
1.4%
1Y
163.2%
Doximity
Market Cap: US$3.9b
Operates a digital platform for medical professionals in the United States.
DOCS
US$21.52
7D
-3.5%
1Y
-64.3%
Parabilis Medicines
Market Cap: US$3.8b
Operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.
PBLS
US$29.55
7D
-3.3%
1Y
n/a
Enliven Therapeutics
Market Cap: US$3.7b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer.
ELVN
US$53.20
7D
4.1%
1Y
134.8%
NewAmsterdam Pharma
Market Cap: US$3.7b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease.
NAMS
US$31.68
7D
-10.2%
1Y
42.7%
Denali Therapeutics
Market Cap: US$3.7b
A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.
DNLI
US$23.29
7D
-12.0%
1Y
68.4%
Adaptive Biotechnologies
Market Cap: US$3.7b
A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
ADPT
US$22.92
7D
8.8%
1Y
120.6%
Alumis
Market Cap: US$3.7b
A clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders.
ALMS
US$28.66
7D
2.0%
1Y
763.3%
iRhythm Holdings
Market Cap: US$3.6b
A digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States.
IRTC
US$110.88
7D
-6.6%
1Y
-18.2%
Brookdale Senior Living
Market Cap: US$3.6b
Owns, manages, and operates senior living communities in the United States.
BKD
US$15.01
7D
4.2%
1Y
93.9%
National HealthCare
Market Cap: US$3.6b
Engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals.
NHC
US$228.16
7D
9.8%
1Y
134.5%
Arcutis Biotherapeutics
Market Cap: US$3.6b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$28.49
7D
2.7%
1Y
94.2%
Organon
Market Cap: US$3.6b
Develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.
OGN
US$13.52
7D
0%
1Y
42.9%
Haemonetics
Market Cap: US$3.5b
A medical technology company, provides a suite of hospital technologies solutions.
HAE
US$77.86
7D
1.3%
1Y
5.5%
Telix Pharmaceuticals
Market Cap: AU$5.1b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$14.91
7D
-8.4%
1Y
-41.0%
Structure Therapeutics
Market Cap: US$3.4b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$48.48
7D
-6.1%
1Y
167.4%
Arcus Biosciences
Market Cap: US$3.4b
A clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
RCUS
US$27.37
7D
-5.4%
1Y
199.1%
IDEAYA Biosciences
Market Cap: US$3.4b
A precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
IDYA
US$36.01
7D
-0.4%
1Y
65.1%
Option Care Health
Market Cap: US$3.4b
Offers home and alternate site infusion services in the United States.
OPCH
US$21.74
7D
0.2%
1Y
-25.5%
1Life Healthcare
Market Cap: US$3.4b
1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand.
ONEM
US$16.47
7D
7.3%
1Y
68.8%
Privia Health Group
Market Cap: US$3.4b
Operates as a national physician-enablement company in the United States.
PRVA
US$26.90
7D
-3.5%
1Y
33.4%
Integer Holdings
Market Cap: US$3.2b
Operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
ITGR
US$95.42
7D
-1.0%
1Y
-14.5%
Acadia Healthcare Company
Market Cap: US$3.2b
Provides behavioral healthcare services in the United States and Puerto Rico.
ACHC
US$34.50
7D
12.9%
1Y
59.4%
CorVel
Market Cap: US$3.1b
Provides workers’ compensation, general and auto liability, and hospital bill auditing and payment integrity solutions.
CRVL
US$61.70
7D
-2.5%
1Y
-35.7%
GRAIL
Market Cap: US$3.1b
A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
GRAL
US$72.62
7D
1.1%
1Y
111.4%
Ansell
Market Cap: AU$4.4b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$31.68
7D
1.7%
1Y
3.3%
MBX Biosciences
Market Cap: US$3.0b
A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.
MBX
US$62.92
7D
3.1%
1Y
435.5%
Disc Medicine
Market Cap: US$2.9b
A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.
IRON
US$76.15
7D
-0.6%
1Y
31.8%
Ultragenyx Pharmaceutical
Market Cap: US$2.9b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
RARE
US$29.28
7D
-13.4%
1Y
11.3%
DENTSPLY SIRONA
Market Cap: US$2.8b
Develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.
XRAY
US$14.05
7D
14.6%
1Y
-10.4%
Supernus Pharmaceuticals
Market Cap: US$2.8b
A biopharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States.
SUPN
US$48.04
7D
1.5%
1Y
44.6%
Celldex Therapeutics
Market Cap: US$2.8b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$35.35
7D
-9.6%
1Y
57.7%
uniQure
Market Cap: US$2.8b
Develops treatments for patients suffering from rare and other devastating diseases in the United States.
QURE
US$40.25
7D
-2.1%
1Y
177.6%